It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Nos últimos quinze anos, o tratamento da insuficiência cardíaca (IC) adquiriu especial relevância nao apenas na cardiologia, mas na medicina interna. Um grande número de novos medicamentos, baseados em uma nova farmacocinética e apoiados por grandes estudos multicêntricos, tem permitido melhorar a sobrevida e a qualidade de vida de inúmeros pacientes espalhados pelo globo. Quando se achou que os fármacos recém-introduzidos no cotidiano tinham controlado sinais e sintomas da IC, surgiram novas alternativas terapêuticas, com destaque para a ressincronizaçao cardíaca. Mais recentemente, outras opçoes de tratamento vêm surgindo, culminando na terapia celular. Este artigo realiza uma revisao da literatura já que este tema se torna de vital importância no dia-a-dia da cardiologia clínica.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer